Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Manager
Telephone: 412-647-9966
Managers
Telephone: 412-647-9975
Other Inquiries
 

Pitt Researchers Awarded More than $1 Million by NIH to Study New Treatments for Pancreatic Cancer Patients

 
PITTSBURGH, Jan. 2, 2014 – The National Institutes of Health (NIH) has awarded a five-year grant of more than $1.5 million to Herbert J. Zeh III, M.D., and Michael T. Lotze, M.D., at the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, to study a novel treatment for pancreatic ductal adenocarcinoma (PDA), the most common form of pancreatic cancer.
 
PDA is the fourth-leading cause of cancer deaths in the United States. The five-year survival of patients suffering from PDA is less than 5 percent.
 
The pair hypothesize that the cancer progresses and is difficult to treat because of a biological pathway called autophagy, a form of programmed cell survival that tumor cells use to avoid apoptosis, or cell death.
 
“It is our hope that blocking autophagy, a new approach to treating cancer, will improve the efficacy of chemotherapy for pancreatic cancer patients,” said Dr. Lotze, professor of surgery, immunology and bioengineering, and assistant vice chancellor, University of Pittsburgh Schools of the Health Sciences.
 
“Our goal with this award is to improve the quality of life for patients with pancreatic cancer,” said Dr. Zeh, associate professor of surgery and chief of the Division of Gastrointestinal Surgical Oncology at UPCI and UPMC CancerCenter.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com